417 related articles for article (PubMed ID: 9766670)
1. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
2. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
3. [Xeroderma pigmentosum. A study in 40 Algerian patients].
Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
[TBL] [Abstract][Full Text] [Related]
4. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts.
Evans MK; Taffe BG; Harris CC; Bohr VA
Cancer Res; 1993 Nov; 53(22):5377-81. PubMed ID: 8221675
[TBL] [Abstract][Full Text] [Related]
5. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
[TBL] [Abstract][Full Text] [Related]
6. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
[TBL] [Abstract][Full Text] [Related]
8. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.
Williams C; Pontén F; Ahmadian A; Ren ZP; Ling G; Rollman O; Ljung A; Jaspers NG; Uhlén M; Lundeberg J; Pontén J
Cancer Res; 1998 Jun; 58(11):2449-55. PubMed ID: 9622088
[TBL] [Abstract][Full Text] [Related]
9. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
10. Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice.
Takeuchi S; Nakatsu Y; Nakane H; Murai H; Hirota S; Kitamura Y; Okuyama A; Tanaka K
Cancer Res; 1998 Feb; 58(4):641-6. PubMed ID: 9485015
[TBL] [Abstract][Full Text] [Related]
11. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
12. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients.
Dumaz N; Drougard C; Sarasin A; Daya-Grosjean L
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10529-33. PubMed ID: 8248141
[TBL] [Abstract][Full Text] [Related]
13. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
Fischer E; Schnyder UW; Jung EG
Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the tumor suppressor gene p53 in xeroderma pigmentosum fibroblasts.
Lavu S; Srivastava M; Srivastava SK
Cancer Lett; 1994 Sep; 85(1):9-12. PubMed ID: 7923108
[TBL] [Abstract][Full Text] [Related]
15. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.
Soufir N; Daya-Grosjean L; de La Salmonière P ; Moles JP; Dubertret L; Sarasin A; Basset-Seguin N
J Natl Cancer Inst; 2000 Nov; 92(22):1841-7. PubMed ID: 11078762
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child.
Giglia G; Bouffet E; Jouvet A; Ohgaki H; Kleihues P; Sarasin A
Int J Cancer; 1999 May; 81(3):345-50. PubMed ID: 10209947
[TBL] [Abstract][Full Text] [Related]
17. U.v.-hypermutability of xeroderma pigmentosum cells demonstrated with a DNA-based mutation system.
Steingrimsdottir H; Beare D; Carr AM; Cole J; Lehmann AR
Oncogene; 1995 May; 10(10):2057-66. PubMed ID: 7761106
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
19. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
[TBL] [Abstract][Full Text] [Related]
20. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
